Cristina Encinas

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

Bruno Paiva, María‐Teresa Cedena, Noemí Puig et al. · Blood · 2016 · 147 citations · Full text

Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy

Josè Antonio Pérez-Simón, Cristina Encinas, Fernando Silva et al. · Biology of Blood and Marrow Transplantation · 2008 · 90 citations · Full text

Prognostic Factors, Immunology, Nih Scoring System +19

Prospective evaluation of a transfusion policy of D+ red blood cells into D− patients

José Ramón González‐Porras, Josè Antonio Pérez-Simón, Jesús Martín et al. · Transfusion · 2008 · 87 citations

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality

Joaquín Martínez‐López, María‐Victoria Mateos, Cristina Encinas et al. · Blood Cancer Journal · 2020 · 75 citations · Full text